Author

N. Chung

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Organism:bacteria (other)· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

N. Sun· 2 shared A. Cioce· 1 shared A. Giraldo-Silva· 1 shared A. Ni Cheallaigh· 1 shared B. Schumann· 1 shared C. Lu· 1 shared C. P. Miller· 1 shared D. C. Briggs· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

N. Sun

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Xylosyltransferase Bump-and-hole Engineering to Chemically Manipulate Proteoglycans in Mammalian Cells

Z. Li, L. Di Vagno, H. Chawla, A. Ni Cheallaigh, M. Critcher, D. Sammon, D. C. Briggs, N. Chung, V. Chang, K. E. Mahoney, A. Cioce, L. D. Murphy, Y.-H. Chen, Y. Narimatsu, R. L. Miller, , B. Schumann

This paper develops a chemical genetic strategy to manipulate proteoglycan glycan attachment sites in mammalian cells using modified xylosyltransferases.

bioRxiv · Dec 20, 2023 · PreprintBiochemistry

Accurate Microbiome Sequencing with Synthetic Long Read Sequencing

N. Chung, M. W. Van Goethem, M. A. Preston, F. Lhota, L. Cerna, F. Garcia-Pichel, V. M. C. Fernandes, A. Giraldo-Silva, H. S. Kim, E. Hurowitz, M. Balamotis, I. Wu, T. Ben Yehezkel

This paper evaluates a synthetic long-read sequencing approach for accurate 16S rRNA gene sequencing, showing improved phylogenetic resolution and accuracy over short-read methods.

bioRxiv · Oct 2, 2020 · PreprintMicrobiology

Validation of a CRISPR/cas9-based technology platform for examining specific immune gene functions in an experimental murine model of IBD

R. Wang, S. Graham, N. Sun, D. McCarthy, R. Peng, J. Erickson, X. Zhu, M. A. Wurbel, R. Dunstan, N. Chung, E. Fiebiger, T. Ghayur, J. Gu

The paper validates a CRISPR/Cas9 platform for studying immune gene functions in a murine IBD model, demonstrating its utility for in vivo validation of therapeutic targets.

bioRxiv · Apr 26, 2019 · PreprintImmunology

VHL Synthetic Lethality Signatures Uncovered by Genotype-specific CRISPR-Cas9 Screens

N. Sun, S. Petiwala, C. Lu, J. E. Hutti, M. Hu, M. Hu, M. H. Domanus, D. Mitra, S. N. Addo, C. P. Miller, N. Chung

The paper uses CRISPR-Cas9 screens in isogenic ccRCC cell lines to identify synthetic lethal partners of VHL, revealing new therapeutic targets for renal cell carcinoma.

bioRxiv · Mar 26, 2019Cancer Biology